Polly Loveton
Medical · Newport Beach, CANPI 1912052499
Payments from drug & device makers
Across 348 payments — averaging $22.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$1K
- AbbVie$981
- EPI Health, LLC$709
- Journey Medical Corporation$547
- Pfizer$496
- Revance Therapeutics, Inc.$359
- plus $4K from 25 others
What the payments were for
- Speaking & faculty fees$801%
- Food & beverage$7,68697%
- Education$1802%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 52 | $1,125 |
| AbbVie(2 entities) | 51 | $981 |
| EPI Health, LLC | 23 | $709 |
| Journey Medical Corporation | 14 | $547 |
| Pfizer | 27 | $496 |
| Revance Therapeutics, Inc. | 14 | $359 |
| Novartis | 9 | $299 |
| Sanofi | 6 | $297 |
| Sun Pharmaceutical Industries Inc. | 8 | $296 |
| Incyte Corporation | 17 | $295 |
| Johnson & Johnson | 7 | $273 |
| Almirall LLC | 9 | $245 |
| Mayne Pharma Commercial LLC | 42 | $240 |
| Dermavant Sciences, Inc. | 9 | $217 |
| UCB, Inc. | 4 | $208 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 8 | $176 |
| Biofrontera Inc. | 9 | $175 |
| LEO Pharma Inc. | 3 | $144 |
| Regeneron Healthcare Solutions, Inc. | 5 | $143 |
| Lilly USA, LLC | 6 | $117 |
| VYNE Pharmaceuticals Inc. | 3 | $97 |
| Amgen | 3 | $82 |
| Merz North America, Inc. | 3 | $78 |
| Solta Medical, A Division Of Bausch Health US, LLC | 4 | $75 |
| Stemline Therapeutics Inc. | 1 | $57 |
| Boehringer Ingelheim | 1 | $51 |
| Sanofi-aventis U.S. LLC | 2 | $43 |
| E.r. Squibb & Sons, L.L.C. | 2 | $41 |
| Arcutis Biotherapeutics, Inc. | 2 | $38 |
| Organon | 3 | $23 |
| Botanix SB Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,946 in reported general payments places this provider in the 90th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clindamycin Phosphate | 12 | $453 |
| ValacyclovirValacyclovir Hcl | 13 | $209 |
| Mupirocin | 16 | $89 |
Paid to pharmacies, not to this prescriber.
Other medical in Newport Beach
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- David DoriguzziLancaster$514K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- Deirdre MoxleyFullerton$149K
- Tri leGardena$127K
- Linda RankLadera Ranch$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.